NISA INVESTMENT ADVISORS, LLC

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 937615 ST. LOUIS, MO

Position in OLMA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$49,214

-$38,218 QoQ

Shares Held

3,934

-32.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#139

of 182 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. OLMA ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,214	3,934	-32.9%	Shares	Sole	2026-08-10
2026-03-31	$87,432	5,864	+55.8%	Shares	Sole	2026-04-30
2025-12-31	$94,100	3,764	+14.5%	Shares	Sole	2026-01-15
2025-09-30	$32,179	3,287	+2.2%	Shares	Sole	2025-10-23
2025-06-30	$13,695	3,215	+3638.4%	Shares	Sole	2025-07-31
2024-12-31	$501	86	+16.2%	Shares	Sole	2025-01-17
2024-09-30	$883	74	+27.6%	Shares	Sole	2024-10-24
2024-06-30	$627	58	+728.6%	Shares	Sole	2024-07-19
2024-03-31	$79	7	-82.5%	Shares	Sole	2024-05-02
2023-12-31	$561	40	-99.9%	Shares	Sole	2024-01-25
2022-03-31	$133,764	31,400	—	Shares	Sole	2022-04-29
No filing history on record for this holder in this stock.